Three-dimensional printing is being steadily deployed as manufacturing technology for the development of personalized pharmaceutical dosage forms. In the present study, we developed a hollow pH-responsive 3D printed tablet encapsulating drug loaded non-coated and chitosan-coated alginate beads for the targeted colonic delivery of 5-fluorouracil (5-FU). A mixture of Eudragit® L100-55 and Eudragit® S100 was fabricated by means of hot-melt extrusion (HME) and the produced filaments were printed utilizing a fused deposition modeling (FDM) 3D printer to form the pH-responsive layer of the tablet with the rest comprising of a water-insoluble poly-lactic acid (PLA) layer. The filaments and alginate particles were characterized for their physicochemical properties (thermogravimetric analysis, differential scanning calorimetry, X-ray diffraction), their surface topography was visualized by scanning electron microscopy and the filaments' mechanical properties were assessed by instrumented indentation testing and tensile testing. The optimized filament formulation was 3D printed and the structural integrity of the hollow tablet in increasing pH media (pH 1.2 to pH 7.4) was assessed by means of time-lapsed microfocus computed tomography (μCT). In vitro release studies demonstrated controlled release of 5-FU from the alginate beads encapsulated within the hollow pH-sensitive tablet matrix at pH values corresponding to the colonic environment (pH 7.4). The present study highlights the potential of additive manufacturing in fabricating controlled-release dosage forms rendering them pertinent formulations for further in vivo evaluation.
In the present study, pure and mixed calcium phosphate/ gypsum cements were prepared and characterized. Characterizations were performed using X-ray diffraction FTIR spectroscopy, thermogravimetric analysis, and Scanning Electron Microscopy. Furthermore, the mechanical properties of the materials were studied and it was found that they depend with the gypsum content. Bioactivity tests after incubation in 2xSBF solution revealed dense apatite structure on the samples containing α-tricalcium phosphate while the pure gypsum specimens showed sparse distributed tiny apatite crystals. Finally, 1% and 2% wt of the anti-inflammatory drug ibuprofen incorporated into the cement paste and the release behaviour of the drug was studied for 18 days in PBS solution. The results showed marked differences in the release profiles of ibuprofen for the different formulations. Complete release of the drug was noticed in the case of pure calcium phosphate cements within 18 days whereas ca. 35-40% of the drug was released from its congeners containing gypsum at the same timescale.
Bone substitute materials are placed in bone defects and play an important role in bone regeneration and fracture healing. The main objective of the present research is fabrication through the technique of 3D printing and the characterization of innovative composite bone scaffolds composed of polylactic acid (PLA), poly (ε-caprolactone) (PCL) while hydroxyapatite (HAp), and/or barium titanate (BaTiO3—BT) used as fillers. Composite filaments were prepared using a single screw melt extruder, and finally, 3D composite scaffolds were fabricated using the fused deposition modeling (FDM) technique. Scanning electron microscopy (SEM) images showed a satisfactory distribution of the fillers into the filaments and the printed objects. Furthermore, differential scanning calorimetry (DSC) measurements revealed that PLA/PCL filaments exhibit lower glass transition and melting point temperatures than the pure PLA filaments. Finally, piezoelectric and dielectric measurements of the 3D objects showed that composite PLA/PCL scaffolds containing HAp and BT exhibited piezoelectric coefficient (d33) values close to the human bone and high dielectric permittivity values.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.